Genasense (Genta Inc.) Journal Article
| Author: | Banerjee, D. |
| Article Title: | Genasense (Genta Inc.) |
| Keywords: | treatment outcome; leukemia; unclassified drug; acute granulocytic leukemia; myeloproliferative disorder; fludarabine; clinical trial; drug tolerability; review; cancer combination chemotherapy; nonhuman; side effect; solid tumor; antineoplastic agents; drug targeting; cytarabine; neoplasms; gene overexpression; proto oncogene; dacarbazine; protein bcl 2; melanoma; quality of life; enzyme inhibition; breast cancer; dexamethasone; drug synthesis; structure activity relation; docetaxel; prostate cancer; gene expression regulation; lung small cell cancer; nonhodgkin lymphoma; drug mechanism; colorectal tumor; colon cancer; mitoxantrone; lymphoma; gene therapy; drug infusion; drug tissue level; drug metabolism; drug half life; chronic lymphatic leukemia; granulocyte colony stimulating factor; oblimersen; proto-oncogene proteins c-bcl-2; clinical trials; oligonucleotides, antisense; drug elimination; antisense oligodeoxynucleotide; thionucleotides; cancer; humans; human |
| Journal Title: | Current Opinion in Investigational Drugs |
| Volume: | 2 |
| Issue: | 4 |
| ISSN: | 1472-4472 |
| Publisher: | Current Drugs Ltd |
| Date Published: | 2001-01-01 |
| Start Page: | 574 |
| End Page: | 580 |
| Language: | English |
| PUBMED: | 11566020 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 21 May 2015 -- Source: Scopus |
